Cancer registry. Azin.Nahvijou, MD, PhD Candidate

Similar documents
Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Planning a Community based Cancer Registry. Cancer Registration: Principles and Methods Edited by Jensen O. M. et al IARC 1991; pages

THE PROCESS OF CANCER REGISTRY DATA QUALITY EVALUATION

A Comprehensive Approach to. International Cancer Survival Benchmarking. SurvMark-2

Cancer incidence in the Republic of Mauritius- 5 Years Review 1997 to 2001

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report

This section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard

RESEARCH COMMUNICATION. An Independent Survey to Assess Completeness of Registration: Population Based Cancer Registry, Chennai, India

Trends in Cancer Survival in NSW 1980 to 1996

RESEARCH COMMUNICATION. Searching for Cancer Deaths in Australia: National Death Index vs. Cancer Registries

General French Cancer Registries The example of the Cancer Registry of Doubs and Belfort Territory

CASEFINDING. KCR Abstractor s Training

Volker Arndt, MD, MPH National Institute for Cancer Epidemiology and Registration (NICER) Zurich

Lung Cancer and Mesothelioma Site Specific Clinical Reference Group Data Quality Report 2009

ENCR Call for Data 21 May 2010

Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India

Setting the stage for change: upgrading the physician cancer case reporting application in New York

PHARMO Database Network

Cancer as a Disease. Linda D. Rego, CTR March 2009

Overview FLORIDA CANCER DATA SYSTEM

GLP in the European Union Ecolabel detergents, GLP and accreditation

Burden and measurement of Noncommunicable diseases

GENERAL ICD- C61: Prostate cancer Page 2 of 18 ICD- C61: Malignant neoplasm of prostate Period of diagnosis % Relative survival N=46,

Cancer and pharmacoepidemiology in Finland. Information sources and research possibilities

Cancer survival in Hong Kong SAR, China,

The Impact of E-Path Technology on the Ontario Cancer Registry. Operations

Faster Cancer Treatment Indicators: Use cases

Cancer Incidences in Rural Delhi

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2017 report Published XX June 2017

Cancer survival and prevalence in Tasmania

Cancer survival in Bhopal, India,

Breast and Colorectal Cancer mortality. in Scotland can we do better?

Canadian Cancer Registry Reference Guide For Years

Population- based cancer survival estimates

Cancer in Estonia 2014

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

Presentation for DHSS 14 September Senior Statistician

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

GENERAL ICD- C73: Thyroid cancer Page 2 of 15 ICD- C73: Malignant neoplasm of thyroid gland Period of diagnosis % Relative survival N=7,95 9

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Appendix 4. Automation in cancer registration

Measuring and predicting cancer incidence, prevalence and survival in Finland

Integration of hospital based breast cancer data and population based data at the Greater Poland Cancer Centre

WHI Extension Appendix A, Form Report of Cancer Outcome (Ver. 8.2) Page 1

Global surveillance of cancer survival

COMMISSION OF THE EUROPEAN COMMUNITIES

Following the health of half a million participants

PET-CT in Oncology: an evidence based approach

Annual report on status of cancer in China, 2010

I.2 CNExT This section was software specific and deleted in 2008.

Current system of childhood cancer registration in Belarus

Macmillan-NICR Partnership: GP Federation Cancer Profiles (with Prevalence )

Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer

Cancer in the Northern Territory :

Required Certificate of Immunization

POPULATION-BASED CANCER REGISTRY, I.R OF IRAN

Cancer Services Performance Indicators. Data Collection Method 2014

Munich Cancer Registry

First Interim Report to the European Commission DG-SANCO for: Grant Agreement No.: (790655) EAIS. December Annex 2

Effective use of access to external data storage systems in the cancer registry of North Rhine-Westphalia (NRW)

Munich Cancer Registry

The health economic landscape of cancer in Europe

Munich Cancer Registry

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Indicators of suicide among people with serious mental illness

Automated UICC-TNM Staging

TARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.

7/11/2011. The impact of cancer survival studies on health policy. NCI prevention budget falls. Cases Deaths Survivors

Landscape of Cancer Registration in South Africa

Report to Waikato Medical Research Foundation

Quality assurance and quality control in pathology in breast disease centers

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Information Services Division NHS National Services Scotland

Attending Physician Statement- Cancer or Carcinoma in-situ

Munich Cancer Registry

Cancer survival in Chennai (Madras), India,

Cancer in Ireland : Annual Report of the National Cancer Registry

Haematological malignancies in England Cancers Diagnosed Haematological malignancies in England Cancers Diagnosed

Moderator & Speaker. Speakers FORUM. Working Group Background Cancer population selection using secondary data sources in the oncology literature

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database

Cancer Mortality, Recent Trends And Perspectives

Cancer Outcomes and Services Dataset: Implications for clinical teams

AJCC TNM 6 th Edition Staging Input Data Dictionary

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century

Downloaded from:

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1995

Information Services Division NHS National Services Scotland

WCPT COUNTRY PROFILE December 2017 HUNGARY

WHI Extension Section 8 Outcomes Page 8-85

WCPT COUNTRY PROFILE December 2017 SWEDEN

Ascertaining and reporting interval cancers in BreastScreen Aotearoa: A protocol NATIONAL SCREENING UNIT (NSU) MINISTRY OF HEALTH

RESEARCH ARTICLE. Some Epidemiological Measures of Cancer in Kuwait: National Cancer Registry Data from

Transcription:

Cancer registry Azin.Nahvijou, MD, PhD Candidate 1

History of Cancer registration: The first efforts to estimate the number of new and existing cases of cancer in a given population were made at the turn of the XIX and XX century in various European countries. In Germany, an attempt was made in 1900 to register all cancer patients who were under medical treatment. The same approach was adopted between 1902 and 1908 in Denmark, Hungary,Iceland, the Netherlands, portugal, Spain and Sweden. The first population based cancer registry was set up in Hamburg( Germany) in 1929 2

History of cancer registration: Country (region) Year of establishment Notification Germany(Hamburg) 1929 Voluntary USA(New York state) USA (Connecticut 1940 1941 Compulsory Compulsory(since 1971) Denmark Canada (Saskatchewan) 1942 1944 Compulsory(since 1987) Compulsory England and Wales(SW Re gion) England and Wales (Liverpool) 1945 1948 Voluntary Voluntary New Zealand Canada (Manitoba) 1948 1950 Compulsory Voluntary Slovenia Canada(Alberta) USA(EL paso) Hungary (Szabolcs,Miskolc,vas) 1950 1951 1951 1951 Compulsory Compulsory Compulsory Compulsory Norway Former USSR Former GDR Finland Iceland 1952 1953 195319531954 Compulsory Compulsory Compulsory Compulsory (since1961) Voluntary 3

International Agency for Research on Cancer Lyon, France 4

Cancer registration: basic principles Cancer registration process: Cancer registration may be defined as the process of continuing, systematic collection of data on the occurrence and characteristics of reportable neoplasms. The overall aim of the cancer registration process is to assess and control the impact of cancer on the community (population). 5

Cancer registration: basic principles Cancer registration process: The cancer registration is an essential part of any rational programme of cancer control. The data from cancer registries can be used in a wide variety of areas of cancer control, such as: etiological research primary prevention secondary prevention health care planning evaluation of patients care 6

Cancer registration: basic principles The cancer registry is the office or institution which attempts to collect, store, analyse and interpret data on persons with cancer. There are two basic types of cancer registries: population-based cancer registry hospital-based cancer registry The population-based cancer registry records all new new cases in a defined population (most frequently a geographical area) The hospital-based cancer registry records all cases in a given hospital, usually without knowledge of the background population (the emphasis is on clinical care and hospital administration). 7

TYPES OF REGISTRIES Hospital-based Registry Population-based Registry Special Cancer Registries 8

Cancer registration: basic principles Objectives of the registry: Collecting and classifying information on cancer cases in order to produce statistics on the occurrence of cancer in a defined population. Linkage of incidence data sets with external data sets (e.g. mortality data sets) to improve completeness and quality of incidence data Evaluation of quality of data provided by particular registries (completeness of data, % of MV, % of DCO/DCN) Analysis of the data collected. 9

Cancer registration: basic principles Planning a population-based cancer registry: The purposes of cancer registration must be clearly defined before a registry is established. The population-based cancer registry must collect information on every case of cancer identified within a specific population over a given time period. 10

Cancer registration: basic principles Planning a population-based cancer registry: The registry operates within a defined geographical area, to be able to: distinguish between residents of the area and those who have come from outside; register cases of cancer in residents treated outside the area; have sufficient information on each case to avoid registering the same case twice; have an access to an adequate number of sources within area. 11

Cancer registration: basic principles Planning a population-based cancer registry: Several condition are necessary to develop a population-based cancer registry: generally available medical care and ready access to medical facilities - so that the great majority of cancer cases will come into contact with the health care system at some point in their illness; system for reporting clinical and pathological data; reliable population data should be available; the cooperation of the medical community is vital to successful functioning of a registry adequate budget must be available (expenses tend to increase in time) 12

Cancer registration: basic principles Planning a population-based cancer registry: Population denominators Accurate and regularly published population data must be available; Population figures by sex and age-groups are required for the registration area (and for any subdivisions which the registry might wish to examine) The cancer registry must use the definitions of population groups, geographical areas, etc. exactly as they are presented in the official vital statistics 13

Cancer registration: basic principles Planning a population-based cancer registry: Size of the population and the number of cases No strict rules concerning the optimal size of the population covered by a single cancer registry In practice, most cancer registries operate with a source population of between one and five million In countries with large populations, autonomous but linked regional registries are usually more effective, e.g. England & Wales or Poland For countries in which national coverage is difficult to achieve, it is preferable to set up smaller registries in representative areas, e.g. SEER Program in the USA, or in India. 14

Cancer registration: basic principles Planning a population-based cancer registry: Physical location of the registry The physical location of the cancer registry is often intimately linked to the administrative dependency of the registry. There are several possible locations, such as: universities oncological (and/or university) hospitals health statistics offices pathology institutes Cancer registries should be as autonomous as possible (to facilitate cooperation with other health agencies). 15

Cancer registration: basic principles Planning a population-based cancer registry: Personnel The level and the quantity of staff depend to a great extent on: the size of the population covered the number of new cases diagnosed annually choice of information to be collected the methods used for case finding recording, coding, and data management practices used In general, it was found in CI5 survey, that one staff member is necessary for each 1000 or so new cases occurring annually in the population covered by the registry. 16

Cancer registration: basic principles Planning a population-based cancer registry: Personnel (cont.) The staff of the registry consists of persons with professional and technical training and experience. The technical staff comprise the record clerks and statistical clerks. Training of the registry personnel at all levels is an important aspect of the cancer registry s operation. Formal, continued training courses recommended Change is a constant Retain registry staff 17

Cancer registration: basic principles Cancer registration methodology Data collection Usually, the main sources of information of a populationbased cancer registry are: information from treatment facilities, such as cancer centers and major hospitals (sometimes private clinics, hospices, homes for the elderly, and general practitioners) information from diagnostic services, especially pathology departments, but also haematological, biochemical and immunological laboratories, X-ray and ultrasound departments, other imaging centers death certificates from the death registration system (if available) 18

SOURCE OF INFORMATION CLINICS LABORATORIES HOSPITAL HOSPITAL VITAL VITAL STATISTICS DEATH CERTIFICATES 19

SOURCE OF INFORMATION 20

Cancer registration: basic principles Cancer registration methodology Data collection The information is collected by: active collection passive reporting Active collection involves registry personnel actually visiting the different sources and abstracting the data on special forms Passive reporting involves health-care workers completing the notification forms developed and distributed by the registry (or sending copies of discharge abstracts to the registry) Mixture of the two above is often used in many registries. 21

Cancer registration: basic principles Cancer registration methodology Data collection - basic data items to be collected: The patient Registration number - assigned by the registry Name Sex Date of birth (or age) - estimate if not known Address - usual residence Ethnic group - if relevant (optional) The tumour Incidence date Most valid basis of diagnosis Topography (site) - coded using ICD-O or ICD-10 Morphology (histology)- coded using ICD-O Behaviour - coded using ICD-O Source of information 22

Cancer registration: basic principles Cancer registration methodology Source of information: type of source physician laboratory hospital death certificate other actual source name of physician laboratory hospital, etc. dates dates of relevant appointments hospital admission diagnostic procedures 23

Cancer registration: basic principles Cancer registration methodology Source of information: Other data items may also be included - however it increases the complexity and cost of the registration process, and should be done only if justified by local needs and if necessary resources are available. The most relevant additional items are: clinical extent of disease before treatment (stage at presentation) follow-up data 24

Cancer registration: basic principles Cancer registration methodology Data collection - additional data items to be collected: The patient personal identification number (e.g. national identity number or social security number) place of birth marital status age at incidence date nationality religion occupation and industry year of immigration country of birth of father and/or mother 25

Cancer registration: basic principles Cancer registration methodology Data collection - additional data items to be collected: The tumour and its investigations certainty of diagnosis method of first detection clinical extent of disease before treatment surgical-cum-pathological extent of disease before treatment TNM system site(s) of distant metastases multiple primaries laterality Treatment initial treatment Follow up date of last contact status at last contact (alive, dead, emigrated, unknown) date of death cause of death place of death 26

Cancer registration: basic principles Cancer registration methodology Registration form The data from the various sources are usually abstracted by using a standard registration form developed according to the needs of the registry. The information on cancer cases should be collected and classified Although data should be collected (and reported) according to local needs and interests, an effort should be made to ensure that comparisons with data from other national and international cancer registries will be possible. 27

28

Cancer registration: basic principles Purposes and uses of cancer registration Epidemiological research descriptive studies cohort studies case-control studies intervention studies ecological studies cross-sectional studies Cancer control patient care survival screening and early detection prevention (primary and secondary) 29

Quality Control 30

Quality control Comparability Completeness Validity or accuracy Timeliness 31

Comparability standardization of practices concerning classification and coding of new cases, and consistency in basic definitions of incidence, such as rules for the recording and reporting of multiple primary cancers occurring in the same individual 32

Quality control Comparability definition of incidence date multiple primaries incidental diagnosis autopsy diagnosis classification and coding death certificates 33

Comparability Quality control definition of incidence date 1. Date of first histological or cytological confirmation a) date when the specimen was taken (biopsy or operation) b) date of receipt by the pathologist c) date of the pathology report. 2. Date of admission to the hospital because of this malignancy. 3. Date of first consultation at the outpatient clinic (only). 4. Date of diagnosis, other than 1, 2 or 3. 5. Date of death, if no information than that the patient has died because of a malignancy. 6. Date of death, if the malignancy is discovered at autopsy. 34

Comparability Quality control definition of incidence date The incidence date should not be later than the date of the start of the treatment, or decision not to treat, or date of death. Discover your potentials for trace back. Change incidence date if new information. 35

Comparability Quality control definition of incidence Be aware: 1. Recurrence or extension of existing cancer and new primaries. 2. Incidental detection of cancer in asymptomatic patients. 3. Detection of cancer in autopsy. 36

Quality control Comparability multiple primaries The recognition of the existence of two or more primary cancers does not depend on time. A primary cancer originates in a primary site or tissue and is not an extension, a recurrence nor a metastasis. Only one tumour shall be recognized in an organ or pair of organs or tissue. 37

Quality control Comparability incidental diagnosis screening ( Cervix, breast, prostate) increased incidence (temporarily?) decreased mean age increased survival time method of detection? 38

Quality control Comparability autopsy diagnosis subset of incidental cancers latent, subclinical disease, competing causes of death basis of diagnosis, method of detection? 39

Quality control Comparability classification and coding ICD-O-3 skin, bladder, nervous system leukemias, lymphomas benign/malignant, CIN, in situ, borderline childhood cancers 40

Quality control Comparability mortality data national statistics corrected mortality data in cancer registry death certificates access (cancer only or all) underlying cause (official statistics) any mention of cancer (DCO, DCN) date (end of follow-up) 41

Completeness the extent to which all of the incident cancers occurring in the population are included in the registry database completeness is a very important attribute only with maximum completeness in case-finding procedures will incidence rates and survival proportions be close to their true values. 42

Completeness Quality control under-diagnosis under-registration selection biases duplicates constant monitoring 43

Completeness Quality control number of sources/notifications per case death certificate method histological verification (HV%) independent case ascertainment re-screening of cases capture/recapture methods mortality/incidence ratio stability of rates over time: between populations, by age group, in children 44

Completeness Quality control types of sources available number of sources per case number of notifications per case number of cases per hospital (other source) record the numbers by case 45

Completeness Quality control number of sources/notifications per case doctors, hospitals, outpatient clinics pathology labs, hematologists autopsy reports suspicion, diagnostics, treatment surgery, radiotherapy, chemotherapy oncologist, gynecological oncologists death certificates other registries, insurance, social security 46

Completeness Quality control number of sources/notifications per case duplicates trace-back confusing information 47

Completeness Quality control death certificate method finds missed cases if death certificates available cancer is lethal patient dies of the cancer certificate correct death in the area of registration 48

Completeness Quality control death certificate method all certificates allow follow-up all cancer diagnoses allow trace-back cancer as the underlying cause only aim at low DCN% and low DCO% 49

Quality control % DCN as indicator of completeness a = registered dead b = registered alive c = unregistered dead (DCN) d = unregistered alive d a + b + c +d then d = bc/a 50

Completeness Quality control death certificate method proportions of DCN cases vary by site increase with age vary by method of detection (HV% vs. radiology) decrease with maturing registry practices decrease with increasing resources 51

Completeness Quality control histological verification (HV%) set local standard independent case ascertainment research data bases (biased?) autopsy series hospital discharge registries (cancer survey) re-screening of cases active and passive registration case- finding study 52

Completeness Quality control capture/recapture methods independent data sources unique identifiers estimates proportions of missing cases 53

Quality control Completeness capture/recapture methods? Source A present absent present a b Source B absent c d if independent sources ad/bc = 1 maximum likelihood estimate d(mle) = bc/a 54

Quality control Completeness capture/recapture methods Path + DC Hospital present absent present 1020 230 absent 99? d(mle) = 230x99/1020 = 22 incompleteness 22 / (1349+22) = 1.6% 55

Completeness Quality control capture/recapture methods can be used as a standard method to compare registries (if similar sources) 56

Completeness Quality control mortality/incidence ratio (M:I) number of deaths and incident cases in the same time period NOT identical patients, but identical diagnoses M:I = (1 - overall survival probability) if incidence and survival steady 57

Completeness Quality control mortality/incidence ratio (M:I) M:I > 1 or M:I > (1 - survival probability) under-registration small registries, rare cancers declining incidence rates inaccurate causes of death 58

Completeness Quality control stability of rates over time between populations by age group in children 59

Validity Quality control proportion of cases in a registry with a given characteristic diagnostic criteria reabstracting and recoding internal consistency % of registered cases with missing information for indicator variable 60

Quality control Validity diagnostic criteria basis of diagnosis - Histology of a primary tumour (including autopsy) - Histology of a metastasis (including autopsy) - Cytology - Specific tumour markers - Clinical investigation (all dg techniques without a tissue dg) - Clinical (before death) - Death Certificate Only - Unknown 61

Validity Quality control histological verification (HV%) or microscopical (incl. biopsy/cytology) primary vs. metastatic vs. infectious HV% of all registered cases (include DCOs) HV% varies by site, available technology, age, stage, sex (all sites combined) 62

Validity Quality control DCO death certificate only measure of completeness and of validity DCO incidence date = date of death If no access to DCs, no DCOs 63

Validity Quality control DCN death certificate notification improve validity of data allocate correct date of diagnosis 64

Quality control Validity reabstracting and recoding identify problems in interpretating source material standardise abstracting and coding determine need for additional training correct (systematical) errors correct existing rules 65

Validity Quality control internal consistency edit checks during or after coding incorrect codes incorrect combinations incorrect order of events, age vs. dates missing information reject flag for check warn for rarity 66

Timeliness Access to recent data is perceived as a priority by users, but, since registries are constantly updating their database as reports are received, and some notifications arrive long after the case was diagnosed, statistics for the recent periods will be incomplete, and will need future updates. There is, therefore, some conflict between the requirement for timely data, and other aspects of data quality, particularly completeness. 67

Timeliness Definition: rapidity at which a registry can collect, process and report sufficiently reliable and complete cancer data Benefit health providers Researchers Reputation of the registry Tradeoff: Timeliness or completeness and accuracy? 68

Timeliness Factors influencing timeliness Efficient procedures Dedicated and well-trained staff Real time reporting Electronic data capture International guidelines for timeliness 6 months-24 months (CDC, SEER, ) 69

Cancer Registry Definition? A Cancer Registration system includes systematic collection, storage, analysis, interpretation and reporting of cancerrelated data 70

فرایند های ثبت سرطان زیر ساخت مدیریت منابع انسان فن آوری اطالعات فرایند های پشتیبان کنت ر ل رسطان ارائه اطالعات به سازمان ها و پژوهش گران تحلیل و گزارش بودجه کنت ر ل کیف داده ارتباط داده ها و تکرارگ یری جمع آوری اطالعا ت از منابع مختلف فرایند های اصیل 71

QUESTIONS???? ARE THERE ANY 72